Telehealth exercise for continence after gynaecological cancer treatment (TELE-CONNECT): a protocol for a co-designed pragmatic randomised controlled trial

Authors: Helena C Frawley, Kim Bennell, Rachel K. Nelligan, Angela Ravi, Nipuni Susanto, Simon Hyde, Orla McNally, Shih-Ern Yao, Karen E Lamb, Peixuan Li, Linda Denehy, on behalf of the TELE-CONNECT study team

Source: BMC Women's Health, Vol 24, Iss 1, Pp 1-12 (2024)

Subject Terms: Gynaecological cancer, Urinary incontinence, Pelvic floor muscle training, Biofeedback, Telehealth, Physiotherapy, Gynecology and obstetrics, RG1-991, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: https://doaj.org/toc/1472-6874

Access URL: https://doaj.org/article/5b9775276b574f3aaf2018d18c289c96

Targeting homologous recombination deficiency in uterine leiomyosarcoma

Authors: Genevieve Dall, Cassandra J. Vandenberg, Ksenija Nesic, Gayanie Ratnayake, Wenying Zhu, Joseph H. A. Vissers, Justin Bedő, Jocelyn Penington, Matthew J. Wakefield, Damien Kee, Amandine Carmagnac, Ratana Lim, Kristy Shield-Artin, Briony Milesi, Amanda Lobley, Elizabeth L. Kyran, Emily O’Grady, Joshua Tram, Warren Zhou, Devindee Nugawela, Kym Pham Stewart, Reece Caldwell, Lia Papadopoulos, Ashley P. Ng, Alexander Dobrovic, Stephen B. Fox, Orla McNally, Jeremy D. Power, Tarek Meniawy, Teng Han Tan, Ian M. Collins, Oliver Klein, Stephen Barnett, Inger Olesen, Anne Hamilton, Oliver Hofmann, Sean Grimmond, Anthony T. Papenfuss, Clare L. Scott, Holly E. Barker

Source: Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-20 (2023)

Subject Terms: Uterine leiomyosarcoma, Homologous recombination deficiency, PARP inhibitors, Rare cancers, Patient-derived xenografts, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1756-9966

Access URL: https://doaj.org/article/90697e9e0fe04ca583a35a4167337ba8

Incorporating laparoscopic interval cytoreductive surgery for advanced ovarian cancer-lessons learnt

Authors: Yael Naaman, Deborah Neesham, Antonia Jones, Rosemary McBain, Tom Cade, Orla McNally

Source: Clinical Surgical Oncology, Vol 2, Iss 4, Pp 100028- (2023)

Subject Terms: Surgery, RD1-811, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2773160X2300020X; https://doaj.org/toc/2773-160X

Access URL: https://doaj.org/article/c197f9d911fa4924bd890769d4a57497

The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models

Authors: Gwo Yaw Ho, Cassandra J. Vandenberg, Ratana Lim, Elizabeth L. Christie, Dale W. Garsed, Elizabeth Lieschke, Ksenija Nesic, Olga Kondrashova, Gayanie Ratnayake, Marc Radke, Jocelyn S. Penington, Amandine Carmagnac, Valerie Heong, Elizabeth L. Kyran, Fan Zhang, Nadia Traficante, Ruby Huang, Alexander Dobrovic, Elizabeth M. Swisher, Orla McNally, Damien Kee, Matthew J. Wakefield, Anthony T. Papenfuss, David D. L. Bowtell, Holly E. Barker, Clare L. Scott

Source: Therapeutic Advances in Medical Oncology, Vol 15 (2023)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1758-8359

Access URL: https://doaj.org/article/acfd52763fdb4a6092abd9806478e071

ENhAncing Lifestyle Behaviors in EndometriaL CancEr (ENABLE): A Pilot Randomized Controlled Trial

Authors: Lara Edbrooke PhD, Pearly Khaw MBBS, FRANZCR, Alison Freimund MBBS, Danielle Carpenter MANP, Orla McNally MB BAO BCh, FRANZCOG, Lynette Joubert PhD, Jenelle Loeliger MND, AdvADP, Anya Traill MPH, Karla Gough PhD, Linda Mileshkin MBBS, FRACP, Linda Denehy PhD

Source: Integrative Cancer Therapies, Vol 21 (2022)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1534-7354; https://doaj.org/toc/1552-695X

Access URL: https://doaj.org/article/770a512ada894347b91ee3f69abb9486

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Authors: Olga Kondrashova, Monique Topp, Ksenija Nesic, Elizabeth Lieschke, Gwo-Yaw Ho, Maria I. Harrell, Giada V. Zapparoli, Alison Hadley, Robert Holian, Emma Boehm, Valerie Heong, Elaine Sanij, Richard B. Pearson, John J. Krais, Neil Johnson, Orla McNally, Sumitra Ananda, Kathryn Alsop, Karla J. Hutt, Scott H. Kaufmann, Kevin K. Lin, Thomas C. Harding, Nadia Traficante, Australian Ovarian Cancer Study (AOCS), Anna deFazio, Iain A. McNeish, David D. Bowtell, Elizabeth M. Swisher, Alexander Dobrovic, Matthew J. Wakefield, Clare L. Scott

Source: Nature Communications, Vol 9, Iss 1, Pp 1-16 (2018)

Subject Terms: Science

File Description: electronic resource

Relation: https://doaj.org/toc/2041-1723

Access URL: https://doaj.org/article/daa72fc740814394b7993401524f3f72